Alessandro Rambaldi to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Alessandro Rambaldi has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.893
-
Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2017 07; 17S:S2-S9.
Score: 0.324
-
Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas. J Clin Oncol. 2016 11 20; 34(33):4015-4022.
Score: 0.310
-
Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology. Leuk Res. 2019 06; 81:88-94.
Score: 0.092
-
Reply to H.J.A. Adams et al and C. Mesguich et al. J Clin Oncol. 2018 07 10; 36(20):2125-2126.
Score: 0.086
-
TP53 in adult acute lymphoblastic leukemia. Leuk Lymphoma. 2018 04; 59(4):778-789.
Score: 0.081